Clinical Research
Copyright ©The Author(s) 2005.
World J Gastroenterol. Jul 14, 2005; 11(26): 4067-4077
Published online Jul 14, 2005. doi: 10.3748/wjg.v11.i26.4067
Figure 1
Figure 1 Healing-time curve of esophagitis in patients treated with H2RA. Statistical significance was achieved at 4, 8, and 12 wk, indicating that high dose H2RAs achieved significantly better healing rates for erosive esophagitis than standard dose H2RAs.
Figure 2
Figure 2 Healing-time curve of esophagitis in patients treated with standard doses of proton pump inhibitors vs H2RAs. At wk 2, 4, 8, proton pump inhibitors significantly healed more patients than did H2RAs.
Figure 3
Figure 3 Healing-time curve of esophagitis in patients treated with standard dose of the newer proton pump inhibitors vs omeprazole. No significant difference in the pooled healing rates between the newer proton pump inhibitors and omeprazole was observed.